STAAR Surgical Income from Continuous Operations 2010-2025 | STAA

STAAR Surgical income from continuous operations from 2010 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
STAAR Surgical Annual Income from Continuous Operations
(Millions of US $)
2024 $-20
2023 $21
2022 $40
2021 $28
2020 $6
2019 $14
2018 $5
2017 $-2
2016 $-12
2015 $-7
2014 $-8
2013 $0
2012 $-2
2011 $1
2010 $-4
2009 $-7
STAAR Surgical Quarterly Income from Continuous Operations
(Millions of US $)
2025-06-30 $-17
2025-03-31 $-54
2024-12-31 $-34
2024-09-30 $10
2024-06-30 $7
2024-03-31 $-3
2023-12-31 $8
2023-09-30 $5
2023-06-30 $6
2023-03-31 $3
2022-12-31 $7
2022-09-30 $10
2022-06-30 $13
2022-03-31 $10
2021-12-31 $8
2021-09-30 $6
2021-06-30 $9
2021-03-31 $5
2020-12-31 $3
2020-09-30 $4
2020-06-30 $-1
2020-03-31 $0
2019-12-31 $6
2019-09-30 $2
2019-06-30 $4
2019-03-31 $1
2018-12-31 $1
2018-09-30 $1
2018-06-30 $2
2018-03-31 $1
2017-12-31 $0
2017-09-30 $1
2017-06-30 $-1
2017-03-31 $-2
2016-12-31 $0
2016-09-30 $-2
2016-06-30 $-2
2016-03-31 $-8
2015-12-31 $-1
2015-09-30 $-2
2015-06-30 $-2
2015-03-31 $-2
2014-12-31 $-3
2014-09-30 $-3
2014-06-30 $-2
2014-03-31 $-1
2013-12-31 $-1
2013-09-30 $1
2013-06-30 $0
2013-03-31 $0
2012-12-31 $-1
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
2011-12-31 $0
2011-09-30 $0
2011-06-30 $1
2011-03-31 $0
2010-12-31 $-1
2010-09-30 $-1
2010-06-30 $-2
2010-03-31 $-1
2009-12-31 $-1
2009-09-30 $-2
2009-06-30 $-1
2009-03-31 $-2
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.380B $0.314B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $85.757B 20.59
Becton Dickinson (BDX) United States $57.228B 13.99
Cardinal Health (CAH) United States $35.365B 17.97
Straumann Holding AG (SAUHY) Switzerland $18.752B 0.00
West Pharmaceutical Services (WST) United States $17.822B 35.61
Cooper (COO) United States $15.043B 19.39
Align Technology (ALGN) United States $10.842B 21.37
Henry Schein (HSIC) United States $8.440B 14.94
Merit Medical Systems (MMSI) United States $5.297B 25.56
DENTSPLY SIRONA (XRAY) United States $2.924B 8.57
CONMED (CNMD) United States $1.728B 12.43
Lifevantage (LFVN) United States $0.165B 16.99
Pro-Dex (PDEX) United States $0.150B 16.44